Stifel raised the firm’s price target on Astera Labs (ALAB) to $100 from $80 and keeps a Buy rating on the shares following a “strong” Q3 beat and “strong” Q4 raise. The firm sees a diversifying revenue ramp with high visibility into calendar year 2025, driven by multiple products and growing content across multiple customers, the analyst tells investors in an earnings recap.